About JeNaCell
JeNaCell is a Healthcare company based in Jena (Germany) founded in 2012, and was acquired by Evonik in August 2021. Dermatology-based skin care products are manufactured for various applications. JeNaCell has raised $902.36 thousand across 7 funding rounds from investors including Evonik, European Union and Innovation Works. JeNaCell offers products and services including Biosynthetic Cellulose and Wound Dressings. Its focus areas include Cosmeceuticals. Its legal entity is JeNaCell GmbH.
Company details
JeNaCell was established in 2012 in Jena, Germany, focusing on the manufacturing of skin care products rooted in dermatology. Operations center on developing and producing formulations targeted at skin health and treatment needs. The company operates within the health and personal care sector, with products distributed through established channels in Europe. Emphasis is placed on scientific approaches to dermatological solutions, supported by local expertise in the region.
- Headquarters Jena, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website jenacell.com/en
- Social LinkedIn
- Acquired by Evonik (Aug 2021)
- Legal Name Jenacell Gmbh
Products & Services of JeNaCell
JeNaCell offers a comprehensive portfolio of products and services, including Biosynthetic Cellulose and Wound Dressings.
Biosynthetic cellulose is developed for innovative medical applications to enhance treatments for wounds and dermatological issues.
Wound dressings are designed for the management of chronic wounds, burns, and post-treatment care in medical aesthetics.
Funding Insights of JeNaCell
JeNaCell has successfully raised a total of $902.36K across 7 strategic funding rounds. The most recent funding activity was a Grant round of $301.4 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $902,363
- Total Rounds 7
- Last Round Grant — $301,397
- First Round $902,363
(Sep 2012)
- Investors Count 7
All 7 funding rounds of JeNaCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $301,397 | Grant | – | – | |
| May 2020 | $142,884 | Grant | – | – | |
| Mar 2018 | $132,508 | Grant | – | – | – |
| Jan 2018 | $129,706 | Grant | – | – | |
| Jan 2016 | $270,649 | Grant | – | – | – |
| Jul 2015 | Series A | – | – | ||
| Sep 2012 | $902,363 | Seed | – | – |
8 investors in total: 8 institutional.
Investors in JeNaCell
JeNaCell has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Evonik, European Union and Innovation Works.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
Software, hardware, and life sciences startups are funded and accelerated. | 1999 | innovationworks.org | Pittsburgh, United States | |
Venture capital and private equity investments are managed by bm|t. | bm-t.de | Erfurt, Germany | ||
Corporate venture capital investments are made by Evonik. | venturing.evonik.com | |||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Offers banking accounts, loans, insurance, and investments for private and business customers. | 1828 | s-jena.de | Jena, Germany | |
Technology innovation is advanced by the STIFT foundation in Germany. | 1993 | stift-thueringen.de | Erfurt, Germany | |
Evonik is recognized as a leader in specialty chemicals innovation. | 1847 | evonik.com | Essen, Germany |
Investor details for JeNaCell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of JeNaCell
4 dated milestones of JeNaCell across 9 years, from founding to its latest funding, stage changes and deals.
- Founded JeNaCell is founded.
- Funding First funding round of $902K.
- Funding Latest funding round, Grant, of $301K.
- Exit Acquired by Evonik.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about JeNaCell
JeNaCell was founded in 2012.
JeNaCell is headquartered in Jena, Germany. It is registered at Jena, Thuringia, Germany.
JeNaCell is a funded company, having raised a total of $902.36K across 7 funding rounds to date. The company's 1st funding round was a Seed of $902.36K, raised on Sep 2012.
JeNaCell was established in 2012 in Jena, Germany, focusing on the manufacturing of skin care products rooted in dermatology. Operations center on developing and producing formulations targeted at skin health and treatment needs. The company operates within the health and personal care sector, with products distributed through established channels in Europe. Emphasis is placed on scientific approaches to dermatological solutions, supported by local expertise in the region.
JeNaCell offers Biosynthetic Cellulose and Wound Dressings.
JeNaCell has 8 investors. Key investors include Evonik, European Union, Innovation Works, STIFT, and High-Tech Gründerfonds.
JeNaCell operates through Jenacell Gmbh.
Yes. JeNaCell was acquired by Evonik in August 2021.